Literature DB >> 9142738

The true clinical significance of renography in nephro-urology.

R G Woolfson1, G H Neild.   

Abstract

Isotopic renography is a non-invasive technique used routinely by the clinician to provide information about kidney structure and function. Whilst there is no doubt of its value in the accurate measurement of glomerular filtration rate and in the detection of parenchymal abnormalities, its role in the diagnosis of renovascular disease (especially in patients with renal insufficiency), the exclusion of obstruction and the evaluation of the patient with either acute renal failure or renal transplant dysfunction remains unproven. In part, this reflects a failure to standardise protocols and rigorously evaluate diagnostic techniques. Recent developments in ultrasound, computerised X-ray tomography and nuclear magnetic resonance now present the clinician with rival techniques and emphasise the need for the clinical development of isotopic renography.

Entities:  

Mesh:

Year:  1997        PMID: 9142738     DOI: 10.1007/bf01267689

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

Review 1.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

2.  iRENEX: a clinically informed decision support system for the interpretation of ⁹⁹mTc-MAG3 scans to detect renal obstruction.

Authors:  Ernest V Garcia; Andrew Taylor; Russell Folks; Daya Manatunga; Raghuveer Halkar; Bital Savir-Baruch; Eva Dubovsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-30       Impact factor: 9.236

Review 3.  The role of nuclear medicine in clinical investigation.

Authors:  E M Prvulovich; J B Bomanji
Journal:  BMJ       Date:  1998-04-11

4.  Evaluation of autosomal dominant polycystic kidney disease by DTPA renal scintigraphy.

Authors:  M Vlajković; A Slavković; S Ilić; M Popović; V Stefanović
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.